Monitor for any future conversion to a 13D filing, which would signal a shift from passive to activist intent. For now, this is a routine passive disclosure with no immediate catalyst.
Price Chart
Executive Summary
HOLD Alapkezelo Zrt., a Hungarian investment fund management company, filed a Schedule 13G disclosing a passive 5.2% stake in Protalix BioTherapeutics, Inc. as of October 14, 2026. This is a new filing, not an amendment, indicating a fresh position of 4,157,791 common shares. The filing certifies no intent to influence control, consistent with a passive investment.
Key Financial Metrics
Key Facts
- HOLD Alapkezelo Zrt. disclosed beneficial ownership of 4,157,791 shares of Protalix BioTherapeutics common stock.
- Stake represents approximately 5.2% of shares outstanding, based on 80,571,642 shares outstanding as of June 30, 2026.
- This is a new Schedule 13G filing (not an amendment), indicating a new passive position.
- The filer is a Hungarian investment fund management company, not a known activist investor.
- Filer certifies the securities were not acquired with the purpose of changing or influencing control of the issuer.
Financial Impact
Passive 5.2% stake valued at approximately $1.2 million based on recent trading prices (estimated from share count and typical PLX price range).
Risk Factors
- No indication of activist intent; unlikely to lead to management changes or strategic shifts.
- Stake is modest at 5.2%, below thresholds that typically signal strong conviction or potential for engagement.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0002086358-26-000006 |
| Document: 0002086358-26-000006-index.html | 0002086358-26-000006 |
| Document: 0002086358-26-000006.txt | 0002086358-26-000006 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 12d ago | SC 13G | $2.70 | awaiting T+20 | — | $2.48 (−8.15%) |
Aug 12, 2026 10w ago | 8-K | $2.62 $2.73 | ▲ +4.20% | ▲ +6.10% | $2.48 (−5.34%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers